Results 151 to 160 of about 209,193 (336)

Arginine-rich Anti-vascular Endothelial Growth Factor Peptides Inhibit Tumor Growth and Metastasis by Blocking Angiogenesis [PDF]

, 2000
Donggoo Bae, Yong-Song Gho, Woong Yoon, Chi‐Bom Chae   +3 more
openalex   +1 more source

Gasotransmitters in Modern Medicine: Promises and Challenges in the Use of Porous Crystalline Carriers

Advanced Healthcare Materials, EarlyView.
This perspective provides an overview of the growing interest in utilizing various gasotransmitters—small gaseous signaling molecules namely nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S)—for several therapeutic applications, with emphasis on the potential use of porous materials as carriers to provide safe and controlled local ...
Rosana V. Pinto, Moisés L. Pinto, Christian Serre   +2 more
wiley   +1 more source

Tumor-Acidity Responsive Polymeric Nanoparticles for Targeting Delivery of Angiogenesis Inhibitor for Enhanced Antitumor Efficacy With Decreased Toxicity. [PDF]

Front Bioeng Biotechnol, 2021
Cong X, Chen J, Xu R.
europepmc   +1 more source

A new angiogenesis inhibitor, FR-111142.

, 1992
TAKANAO OTSUKA, Toshihiro Shibata, YASUHISA TSURUMI, Shigehiro Takase, MASAKUNI OKUHARA, Hiroshi Terano, MASANOBU KOHSAKA, Hiroshi Imanaka   +7 more
openalex   +2 more sources

Lycium‐Barbarum Polysaccharide‐Loaded Dual‐Crosslinked Rigid Hydrogel Enhances Bone Healing in Diabetic Bone Defects by Scavenging Reactive Oxygen Species

Advanced Healthcare Materials, EarlyView.
A novel hydrogel (HLBP) incorporating natural polysaccharides from goji berries is developed to enhance diabetic bone defect healing. The hydrogel efficiently scavenges ROS, improves osteogenic differentiation, and promotes in vivo bone regeneration. This strategy offers a biocompatible and localized approach, overcoming the challenges of traditional ...
Wenjie Zhong, Wenao Liao, Lingcong Xu, Niezhenghao He, Ke Xu, Caiyuan Liu, Fei Wang, Wei Zhang, Jiang Hu, Haowen Cui   +9 more
wiley   +1 more source

Correlation Between Treatment‐Related Adverse Events and Efficacy of Camrelizumab in Combination With Apatinib in Patients With Unresectable Hepatocellular Carcinoma

Cancer Medicine
Background The relationship between treatment‐related adverse events (TRAEs) and efficacy in patients receiving immune checkpoint inhibitors (ICIs) combined with anti‐angiogenic therapy remains unclear.
Ting Zhang, Sicheng Du, Ying Zhang, Rongrui Liu, Juan Li, Chuanhua Zhao, Jianming Xu   +6 more
doaj   +1 more source

Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts

, 1992
Takaaki Sasaki
openalex   +2 more sources

TNP‐470 and recombinant human interferon‐α2a inhibit angiogenesis synergistically [PDF]

, 2000
Monica Minischetti, Angelo Vacca, Doménico Ribatti, Monica Iurlaro, Roberto Ria, Antonio Pellegrino, Giampietro Gasparini, And Franco Dammacco   +7 more
openalex   +1 more source

Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy

Advanced Healthcare Materials, EarlyView.
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq, Punnya Anil Kumar Jeeja, Sudip Kumar Dam, Sabya Sachi Das, Juan L. Vivero‐Escoto   +4 more
wiley   +1 more source

Questionnaire survey of angiogenesis inhibitor-related oral complications based on a nation-wide study in Japan. [PDF]

J Dent Sci, 2021
Yamada SI, Kurita H, Tanaka A, Miyata M, Morimoto Y, Yamaguchi A, Yanamoto S, Yoshikawa H, Imai Y.   +8 more
europepmc   +1 more source